People · Operator
Named in public records as an officer, director or promoter · active 2013–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Siamab Therapeutics, Inc. | — | Biotechnology | Seed | $8.8M | $29.5M | 2013 |
Brad Curley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad Curley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sundar Subramaniam | 1 | 6 |
| PETER KROON | 1 | 3 |
| Jeffrey Behrens | 1 | 3 |
| Mark Hattendorf | 1 | 2 |
| Nissi Varki | 1 | 1 |
| Ajit Varki | 1 | 1 |
| Robert Mashal | 1 | 1 |
| Gary Pforzheimer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.